102 On the flip side, numerous groups are advocating for the incorporation of novel markers, such as a complicated karyotype55 or epigenetic subsets, 27,28 into clinical practice. Each one of these novel prognostic and/or predictive types will must be validated in cohorts of sufferers dealt with with specific brokers. Essential: https://audreyf186zfn3.bmswiki.com/user